SYNTHOS RESEARCH

SSR Mining SSRM

Basic Materials · Gold · Synthos Deep Dive · 2026-07-06

$37.29
Watch

The Overview

SSR Mining digs gold (about 70% of sales) and silver (about 23%) out of mines in the United States, Canada, and Argentina. When the gold price is high — as it has been — the company mints money: last quarter it kept 61 cents of every revenue dollar as gross profit and it holds more cash than debt.

The stock looks strikingly cheap: about 7 times next year's expected earnings, versus roughly 27 times for the market. But there are three honest catches. First, those earnings depend almost entirely on the gold price staying elevated — a miner cannot control the price of what it sells. Second, the company's own analyst estimates show profits peaking next year and then shrinking every year through 2030 as its mines age. Third, this company had a genuine catastrophe in 2024 — a collapse at its largest mine, in Türkiye — and the final accounting for that exit is still hitting the income statement this year.

Here's what our three scores mean in everyday terms:

The one big worry: if gold corrects meaningfully, the "7× earnings" math evaporates at the same moment the stock's momentum crowd exits — a double hit. That's why we'd rather engage ~15% lower, where a gold pullback is partly pre-paid.


Putting a number on it: our fair-value estimate is $38 against a current price of $37.29 — real upside if our numbers are right.

Our summary metrics

Downside Risk (lower = safer)7/10High

Net cash and a 5.3× current ratio, but a single-commodity earnings stream, a recent catastrophic mine failure (2024) with a −$365M discontinued-ops charge still landing in Q1-26, ~28% Argentina revenue, and only ~5 covering analysts.

Growth Quality5/10Moderate

Revenue +66.6% FY25 and +83.7% YoY in Q1-26 with ROIC ~11% and cash-rich income quality (1.46) — but the growth is gold-price + acquisition driven, and consensus EPS fades from $4.98 (2027E) to $2.68 (2030E).

Exponential Potential2/10Low

Not an exponential — a cyclical commodity producer whose own analyst deck models revenue and EPS declining after 2027 as mine plans deplete; the upside driver is the gold price, not compounding.

Fair value$38 $22–$47
What does “fair value” mean?

Fair value is Synthos’s estimate of what one share is worth today, based on our model of the company’s future cash generation and the risks to it. It is not a price target or a prediction of where the stock trades next quarter — it’s the price where we think risk and reward are balanced. Above it, you’re paying for outcomes better than our base case; below it, the market is offering a margin of safety.

The model’s inputs and weightings are proprietary — they’re the product. What we publish is the output, plus an independent, public-math cross-check further down the page (“Check our number”) so you can judge it for yourself.

What do the 5 tiers mean? (Core · Tactical · Watch · Hold · Avoid)
Buy — CoreOwn it as a foundation — start or add now, size it for years, let dips be gifts.
Buy — TacticalGood price + confirmed trend + a defined exit — buy the setup, not a marriage.
WatchWe want the business, just not at this price/setup — act only when the listed trigger hits.
HoldFine to keep if you own it — no reason to buy more; new money does better elsewhere.
AvoidDon't own it — the problem is the business or the expectations, so a cheaper price won't fix it.

Exponential Potential

Exponential Potential2/10Low

Not an exponential — a cyclical commodity producer whose own analyst deck models revenue and EPS declining after 2027 as mine plans deplete; the upside driver is the gold price, not compounding.

What could take this further than the base case — and where the market may be underpricing it. Full forward-growth and acceleration math in Deeper analysis, §4 below.

Deeper analysis

Technicals, fundamentals, valuation, and the full expert-claim evidence panel — the detail behind the numbers above.

Check our number Market-implied growth ≈ 13%/yr This isn’t how we calculate fair value — it’s public math you can verify yourself. To justify today’s $37, earnings would have to compound roughly 13% a year for 10 years (9% discount rate). Analysts forecast ~12%/yr, so the market is pricing in about what the Street expects.

Reference table

Street consensus$39.50 (high $40 / low $39 — effectively two targets; 7 Buy · 3 Hold · 1 Sell) — context, not our anchor
Valuation26.6× trailing EPS (depressed by a discontinued-ops charge) · ~6.9× 2026E · ~6.2× 2027E · EV/EBITDA 7.1× TTM · P/B 1.74× · FCF yield 7.6%
TechnicalsUptrend cooling — $30.64, −14% off the 52-wk high ($35.74), above 50/200-DMA, RSI 64, but 3-mo return −3.0% vs SPY +14.6%
ConvictionNone — 0 expert voices, 0 traceable KB claims; screen-surfaced, fundamentals-only note
Position sizingNone today (Watch); if triggered near ~$26, satellite ~1–2% max — commodity single-name risk

What the experts actually said 1 traceable claims on SSRM · showing the highest-conviction voices

“SSR Mining ($6B cap, $1.5B net cash, buying back stock, pure North American play at 7x earnings, half peers' valuation) can double within a year even in flat gold.”
Macro Dirtbullishconviction 80n/amacro_dirt-LDrOV4i0EU4:83171b3067

Every claim reconciles to a real claim_id in the Synthos knowledge base — this is the evidence the verdict is built on, not vibes. Management (the company itself) is shown but half-weighted; one cautionary voice is included on purpose.

Price & moving averages 12 months · 50 & 200-day averages · 52-week range

816253342Aug '25Nov '25Jan '26Apr '26Jun '26Aug '2652w hi $39Price 3750-DMA 30200-DMA 2852w lo $18

Solid line = price · dashed line = 50-day average · dotted line = 200-day average · the two thin horizontal lines mark the 52-week high and low. Price above both averages is an uptrend.

Data summary: last close $37.29, 24% above the 50-day average ($30), 35% above the 200-day average ($28) — an uptrend. 5% below the 52-week high of $39, 104% above the 52-week low of $18.

Bollinger Bands 20-day average ± 2 standard deviations

1019273544Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26Price 3720-day avg 33

The shaded band widens when the stock gets more volatile. Riding the upper edge = strong momentum (sometimes stretched); the lower edge = weak / potentially oversold.

Data summary: price $37.29 is currently inside the band (band $26–$41).

RSI (14) momentum gauge · 0–100

705030Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26RSI 64.1

Above 70 (overbought zone, shaded) = overbought, below 30 (oversold zone, shaded) = oversold. Currently 64.

MACD 12 / 26 / 9 · trend & momentum

0Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26MACD 2.7signal 2.2

The MACD line crossing above the signal line (bars flip to the up color) = momentum turning up; crossing below (bars flip to the down color) = turning down. Bar height = the size of that gap.

Data summary: MACD is currently above its signal line by 0.48, positive momentum.

Relative performance vs S&P 500 & its sector (XLB (sector)), set to 100 a year ago

82117153189224Aug '25Nov '25Jan '26Apr '26Jun '26Aug '26SSRM 204S&P 500 119XLB (sector) 115

Solid = SSRM · dashed = S&P 500 · dotted = XLB (sector). A rising line means it is beating that benchmark — the sector line shows whether it is a leader or laggard within its own group.

Forward revenue & earnings actual → estimate · "FY" = fiscal year, "E" = estimate

01123$1BFY23EPS $1$1BFY24EPS $0$2BFY25EPS $2$2BFY26EEPS $4$3BFY27EEPS $5$2BFY28EEPS $4$2BFY29EEPS $4$2BFY30EEPS $2

Darker bars = actual results, brighter = analyst estimates. Taller bars to the right = expected growth.

Key stats an RIA wants

Price$37.29
Market cap$8B
P/E trailing29×
P/E FY26E / FY27E9× / 8×
EV / Sales3.9×*
EV / EBITDA8.1×*
Gross margin57.5%
Net margin13.9%
Dividend yield0.08%
Beta0.9
52-wk range$18 – $39
RSI(14)69
50 / 200-DMA$30 / $28
12-mo return+102% (SPY +19%)
Street target$39 ($39–$39)
Analyst grades8 Buy · 3 Hold · 0 Sell
FMP ratingA-
Next earnings2026-08-04 (Q2 2026 earnings; Street EPS est $0.75, revenue est ~$522M)

* Enterprise value recomputed in-house: the data vendor nets cash but omits short-term investments, overstating EV for cash-rich balance sheets. EV multiples marked * use market cap + total debt − cash − short-term investments.

1. What it is

SSR Mining (Nasdaq: SSRM) is a precious-metals producer with operating assets in the USA, Canada, and Argentina, plus a legacy position in Türkiye. Founded 1946, headquartered in Denver, CO; CEO Rodney Antal; ~4,800 employees. Reported segments per the profile: Çöpler (Türkiye — suspended/exiting, see below), Marigold (Nevada), Cripple Creek & Victor (Colorado — the CC&V acquisition shows up as −$107.8M acquisitionsNet in the FY25 cash-flow statement), Seabee (Saskatchewan), and Puna (Argentina, silver/lead/zinc).

Revenue mix (FY25, from filings):

The strategic story: a US-weighted mid-tier producer that replaced its lost Turkish production by buying Cripple Creek & Victor and riding record gold prices — production quality up, jurisdiction risk down, but commodity dependence total.

2. The expert thesis

No expert-panel coverage — this note is fundamentals-driven. A search of the Synthos knowledge base (53k claims) returns zero traceable claims on SSRM from any tracked voice. That is the honest house standard for screen-surfaced names: this dive was triggered by the quant momentum screen (+133% 12-mo), not by expert conviction, and the conviction rating is None by construction. There is no bull thesis to reconcile and no cautionary short thesis either — everything in §3 onward is built from filings, consensus estimates, and technicals in the data file.

3. Synthos scores & the Bull / Base / Bear cases

The one-glance judgment — three scores, 0–10, each anchored to real metrics (not probabilities we can't honestly calibrate):

Score0–10The read
Downside Risk (lower = safer)7 · HighNet cash (net debt −$122.9M FY25), current ratio 5.3×, beta 0.88 — the balance sheet is genuinely strong. Against that: a single-commodity earnings stream, ~28% Argentina revenue, a 2024 operational catastrophe whose accounting tail (−$365.3M discontinued-ops in Q1-26) is still landing, thin coverage (~5 EPS analysts), and a stock that has already run +160% off its 52-week low. Beta understates commodity risk.
Growth Quality5 · ModerateFY25 revenue +66.6%, Q1-26 +83.7% YoY at a 61.3% gross margin; ROIC ~11.1%, income quality 1.46 (cash exceeds accounting income — the good direction). But the growth is bought (CC&V) plus priced (gold), not compounded — and consensus has EPS peaking 2027 ($4.98) then fading to $2.68 by 2030.
Exponential Potential2 · LowThe second derivative is negative by design: consensus revenue $2.44B (2026E) → $2.68B (2027E) → $2.59B (2028E) → $2.26B (2029E) → $1.99B (2030E). Mine plans deplete; there is no TAM story. Upside comes from the gold price, not acceleration.

The three cases (our own scenario model — assumptions shown; each target is a ~12–18-month fair value). We deliberately do not attach probabilities: the base case is the expected path; the cases bound the range. All multiples are applied to consensus EPS — labeled assumptions, not a DCF with false precision.

CaseKey assumptionsFair value
BullGold stays elevated through 2027; CC&V + Marigold deliver; 2027E EPS $4.98 earns a ~9.5× multiple (still a discount to market — it's a cyclical peak).~$47 (+53%)
Base (our anchor)2026E EPS ~$4.41 roughly lands; a mid-tier producer at peak-cycle earnings deserves ~8.5× — essentially in line with the Street's (very thin) $39.50 consensus.~$38 (+24%)
BearGold corrects 15–20%; EPS compresses toward the out-year fade path (~$2.70) faster than modeled, at ~8×; momentum holders exit simultaneously.~$22 (−28%)

Synthos fair value = the base case, ~$38 (+24%), full range $22–$47. Two honesty flags on the inputs: (1) the Street "consensus" target of $39.50 is a high of $40 and a low of $39 — effectively two analysts, so it corroborates rather than anchors; (2) the consensus estimate set is internally inconsistent (2026E net income avg $957M exceeds 2026E EBITDA avg $529M, which is impossible — different analyst pools per line), so we lean on the EPS line (5 analysts) and hold it loosely. This is a tracked call — the Forecaster Scorecard grades it once it matures.

4. Exponential Potential

Synthos separates compounders (durable high returns on capital) from exponentials (accelerating multi-baggers). SSRM is neither — it is a cyclical:

Exponential Potential: Low (2/10). If you want gold exposure, this is a leveraged way to rent it — but nothing here compounds on its own.

5. Financials (real numbers — FMP annual/quarterly)

6. Valuation — priced in or room?

The headline multiples are cheap-with-an-asterisk: 26.6× trailing (distorted by the Q1-26 discontinued-ops charge; on FY25's clean $1.85 diluted it's ~16.6×), ~6.9× 2026E EPS ($4.41) and ~6.2× 2027E ($4.98), EV/EBITDA 7.1× TTM, EV/sales 3.1×, P/B 1.74×, FCF yield 7.6%. FMP's letter rating is B+ (overall 3/5; DCF score 4/5, P/E score 1/5 on the distorted trailing number). The reverse read: at ~$30.64 the market is already discounting the consensus EPS fade — a flat gold price makes this cheap, a rising one makes it very cheap, and a falling one makes the multiple meaningless because the E collapses. Street targets (context only): $39.50 consensus, but the $39–$40 high-low band reveals it's ~two contributors — far too thin to anchor on. Grades: 7 Buy · 3 Hold · 1 Sell. Our base case ($38, ~8.5× 2026E) lands beside the Street's number by arithmetic, not by deference. This is not a "the market is missing it" setup; it is a "the market is charging a proper cyclical discount" setup.

7. Technicals (from the tech block)

8. Moat & competitive position

Miners don't have moats in the franchise sense; they have asset quality and jurisdiction. SSRM's post-Çöpler portfolio is genuinely improved on the second axis: ~61% of revenue from the United States (Nevada + Colorado), ~11% Canada — versus peers carrying West-African or deep-South-African risk. Asset quality is mid-tier: Marigold is a large, long-lived run-of-mine heap leach; CC&V adds scale in Colorado; Seabee is small but high-grade; Puna is a solid silver producer with Argentina attached. What SSRM does not have: the scale of an AngloGold ($42.5B) or Kinross ($29.5B), or the royalty-model economics of Wheaton ($52.3B) / Franco-Nevada ($41.0B) that the FMP peer list mixes in.

Peer set (FMP-supplied, market cap): AngloGold $42.5B · Wheaton $52.3B · Franco-Nevada $41.0B · Gold Fields $31.0B · Kinross $29.5B · Pan American $19.0B · Royal Gold $14.0B · Coeur $11.1B · Harmony $10.3B · Equinox $8.1B · Eldorado $6.7B · SSRM $6.36B · B2Gold $5.4B · OR Royalties $5.8B · Sandstorm $3.6B · Centerra $3.3B · Fortuna $2.6B · DRDGOLD $1.9B. Caveat: royalty companies (WPM, FNV, RGLD, SAND, OR) deserve structurally higher multiples and shouldn't be compared 1:1; against operating mid-tiers, SSRM's ~7× forward EPS and 7.1× EV/EBITDA read as middle-of-the-pack cheap, not anomalous.

9. Management, capital allocation & guidance

10. Catalysts & what to watch

Thesis tripwires (what would change the call): a close below the 200-DMA (~$26) with gold falling — that's the entry zone only if gold is the reason, not an SSRM-specific failure; any new operational incident at Marigold/CC&V/Seabee (instant Avoid pending facts); consensus 2027E EPS revised below ~$4.00; or an adverse surprise in the Çöpler exit liabilities.

11. Key risks

12. Verdict, position sizing & monitoring

Watch. The business case is real: a net-cash, US-weighted mid-tier producer earning a 61% quarterly gross margin, generating a 7.6% FCF yield, beating estimates four of the last five quarters, at ~7× forward earnings and 1.7× tangible book. The reasons this is not a Buy today: the forward earnings are peak-cycle and consensus-modeled to fade −46% by 2030; the stock has already tripled off its low and is lagging the market by ~18 points over the last three months; the Çöpler accounting tail is still landing; the Street backdrop is two price targets and five analysts; and we have zero expert-panel conviction behind it. At ~$26 (the rising 200-DMA, ~5.9× 2026E EPS, ~30% below base fair value) the risk/reward flips and this becomes a tactical buy if gold — not SSRM — is the reason for the dip.


Provenance & disclosures